Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
Complex percutaneous coronary intervention (PCI) patients are a high-risk population for ischemic complications. Antiplatelet therapy in such patients remains controversial, as the beneficial effects of more potent agents use or prolonged dual antiplatelet treatment (DAPT) on atherothrombotic compli...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2020-11-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articles/type-and-duration-of-dual-antiplatelet-therapy |